740P Anti-cytotoxic T-lymphocyte antigen-4 (CTLA 4) probody BMS-986249 ± nivolumab (NIVO) in patients (pts) with advanced cancers: Updated phase I results
| Autor: | Gutierrez, M., Friedman, C.F., Long, G.V., Ascierto, P.A., Melero, I., Richards, D., Bastos, B.R., Moreno Garcia, V., Uemura, M., Conkling, P., Corr, B.R., Kim, A.M., Zhu, L., Hammell, A., Perumal, D., Chouzy, A., Benavente, F., Awosemo, O., Hannah, A., Le, D.T. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S882-S882 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|